Search research articles
Contact Us
Filters
Showing results (191-200 of 2,583) with videos related to
Page
of 259
Sort By:
Hearing Research
|
January 1, 1987
Some organic acids attenuate the effects of furosemide on the endocochlear potential
L P Rybak, C Whitworth
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
January 3, 1983
[Accidental hypothermia]
W Lubczyńska-Kowalska, M Rybak
American Journal of Otolaryngology
|
September 1, 1988
Quinine reduces noxious cochlear effects of furosemide and ethacrynic acid
L P Rybak, C Whitworth
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|
March 12, 2005
[Mechanisms of immunosuppression in leukemia]
Włodzimierz Luczyński, Maryna Krawczuk-Rybak
Plants (Basel, Switzerland)
|
January 21, 2023
Nanopriming of Barley Seeds-A Shotgun Approach to Improve Germination under Salt Stress Conditions by Regulating of Reactive Oxygen Species
Danuta Cembrowska-Lech, Kinga Rybak
Antimicrobial Agents and Chemotherapy
|
May 23, 2003
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model
Raymond Cha, Michael J Rybak
Current Opinion in Otolaryngology & Head and Neck Surgery
|
September 23, 2003
Ototoxicity: bioprotective mechanisms
Leonard P Rybak, Thomas Kelly
Annals of the New York Academy of Sciences
|
June 8, 2000
Ototoxicity. Amelioration by protective agents
L P Rybak, S Somani
Advances in Medical Sciences
|
January 26, 2008
Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
A Kitszel, M Krawczuk-Rybak
Antimicrobial Agents and Chemotherapy
|
March 21, 2018
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA
Nikki Tran, Michael J Rybak
Page
of 259
Search research articles
Search
Showing results (191-200 of 2,583) with videos related to
Sort By:
Page
of 259
Hearing Research
|
January 1, 1987
Some organic acids attenuate the effects of furosemide on the endocochlear potential
L P Rybak, C Whitworth
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
January 3, 1983
[Accidental hypothermia]
W Lubczyńska-Kowalska, M Rybak
American Journal of Otolaryngology
|
September 1, 1988
Quinine reduces noxious cochlear effects of furosemide and ethacrynic acid
L P Rybak, C Whitworth
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|
March 12, 2005
[Mechanisms of immunosuppression in leukemia]
Włodzimierz Luczyński, Maryna Krawczuk-Rybak
Plants (Basel, Switzerland)
|
January 21, 2023
Nanopriming of Barley Seeds-A Shotgun Approach to Improve Germination under Salt Stress Conditions by Regulating of Reactive Oxygen Species
Danuta Cembrowska-Lech, Kinga Rybak
Antimicrobial Agents and Chemotherapy
|
May 23, 2003
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model
Raymond Cha, Michael J Rybak
Current Opinion in Otolaryngology & Head and Neck Surgery
|
September 23, 2003
Ototoxicity: bioprotective mechanisms
Leonard P Rybak, Thomas Kelly
Annals of the New York Academy of Sciences
|
June 8, 2000
Ototoxicity. Amelioration by protective agents
L P Rybak, S Somani
Advances in Medical Sciences
|
January 26, 2008
Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
A Kitszel, M Krawczuk-Rybak
Antimicrobial Agents and Chemotherapy
|
March 21, 2018
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA
Nikki Tran, Michael J Rybak
Page
of 259